Eric Lefebvre, Chief Medical Officer at PLIANT THERAPEUTICS, INC. (PLRX), sold 36,956 shares at $11.20 ($414K) on 2025-01-17, disclosed to the SEC on 2025-01-22.
Scheduled sale ($414k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.20 | 18,478 | $207K | 50.0% |
| 2 | $11.20 | 18,478 | $207K | 50.0% |
| Total | $11.20 avg | 36,956 | $414K | 100% |
| Filing → |
| PLRX | SELL | 2023-07-19 | $804K | — | Filing → |
| PLRX | SELL | 2023-04-03 | $596K | — | Filing → |
| PLRX | SELL | 2023-01-25 | $2.3M | — | Filing → |